A Mutated Prostatic Acid Phosphatase (PAP) Peptide-Based Vaccine Induces PAP-Specific CD8+ T Cells with Ex Vivo Cytotoxic Capacities in HHDII/DR1 Transgenic Mice
Article in Cancers (April 2022)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
The Prostate Cancer Immune Microenvironment, Biomarkers and Therapeutic Intervention
Article in Uro (April 2022)
A multi-immune gene prognostic model for evaluation of survival and prognosis of colorectal cancer
Preprint in Research Square (March 2022)